Entwine Bio utilizes AI-driven RNA splicing programming to engineer specific proteins within cells, enabling precise control over proteome composition. This technology addresses the challenge of customizing protein functions for applications in therapeutics and biotechnology.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for modifying protein function within cells are limited in their precision and ability to target specific proteome compositions. Traditional protein engineering approaches often lack the necessary control over RNA splicing, hindering the development of customized protein functions for therapeutic and biotechnological applications.
Solution
Entwine Bio is developing an AI-driven RNA splicing platform to precisely engineer proteins within cells, enabling fine-grained control over proteome composition. The technology leverages machine learning algorithms to predict and manipulate RNA splicing patterns, allowing for the creation of proteins with customized functions. By targeting RNA splicing, Entwine Bio's approach offers a novel way to modulate protein activity and expression, opening up new possibilities for therapeutic interventions and biotechnological innovations. This platform aims to overcome the limitations of existing protein engineering techniques by providing a more precise and programmable method for controlling protein function.
Target Audience
The primary target audience includes researchers and companies in the fields of therapeutics and biotechnology who are seeking advanced tools for protein engineering and proteome manipulation.
Features
- AI-driven platform for predicting and manipulating RNA splicing patterns
- Ability to engineer specific proteins within cells with high precision
- Customizable protein function through targeted RNA splicing modulation
- Potential applications in therapeutics and biotechnology